Sarmad Sadeghi, MD
University of Southern California
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Sarmad Sadeghi, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:42 UTC. Open this list on ClinicalTrials.gov
- Ph2/Ph3NCT06493552 · Modular Trial of sEphB4-HSA in EphrinB2-High Solid TumorsVasgene Therapeutics, Inc · recruiting · Muscle-Invasive Bladder Carcinoma, Metastatic Urothelial Carcinoma · principal investigator
- Ph2NCT04486781 · A Study of Pembrolizumab+ sEphB4 in Metastatic Urothelial CarcinomaVasgene Therapeutics, Inc · unknown · Metastatic Urothelial Carcinoma · principal investigator
- Ph2NCT02717156 · Multicohort Phase II Trial of sEphB4-HSA+Pembrolizumab in Solid TumorsUniversity of Southern California · active not recruiting · Stage IV Bladder Urothelial Carcinoma, Prostate Cancer, Urothelial Carcinoma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 08:42 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Cancer Research Training and Education CoordinationP30CA014089 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI Josh Neman-Ebrahim · fiscal years 2000 to 2026Named on NCT02717156
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.